Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-04-29

Clinical Trial Update: Antiplaque Effect of Essential Oils and 0.2% Chlorhexidine on an in Situ Model of Oral Biofilm Growth. [Phase 4]

View source ↗

Summary

Phase 4 clinical trial from the University of Santiago de Compostela assessed the antiplaque effects of essential oils versus 0.2% chlorhexidine mouthwash in an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Chlorhexidine digluconate 0.2% mouthwash (Chlorhexidine digluconate)
  • Essential Oils Mouthwash (essential oils mouthwash)

Snippet

Sponsor: University of Santiago de Compostela | Conditions: Oral Biofilm, Mouthwash | Phase 4 | Status: COMPLETED